Bio Essence Corporation
BIOE
$0.206
-$0.008-3.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.40M | -1.56M | -680.10K | -659.10K | -971.80K |
| Total Depreciation and Amortization | 1.20K | -29.40K | -13.20K | 2.70K | 4.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.20M | 1.25M | 81.40K | -17.10K | 201.40K |
| Change in Net Operating Assets | 818.80K | 341.60K | -93.50K | -292.30K | -260.10K |
| Cash from Operations | 623.90K | -3.30K | -705.20K | -965.50K | -1.03M |
| Capital Expenditure | -- | 0.00 | -3.60K | -3.60K | -3.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00 | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00 | -87.90K | -91.50K | -91.50K | -91.50K |
| Total Debt Issued | 0.00 | 331.30K | 849.90K | 1.15M | 1.18M |
| Total Debt Repaid | -613.10K | -123.30K | 42.90K | -10.70K | -1.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.30K | -86.90K | -86.90K | -86.90K | -68.10K |
| Cash from Financing | -622.50K | 121.00K | 805.80K | 1.06M | 1.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.20K | 29.90K | 9.10K | 0.00 | -6.10K |